banner about

Jorge Almeida, PhD

JorgeSenior Scientist - Clinical Research Coordinator

Dr. Almeida is bioscientist who was trained in Biology, Microbiology, and Genetics at University of Lisbon in 2005. He obtained his PhD in Immunology at University Pierre et Marie Curie in Paris 2009. After that, Dr. Almeida worked as Postdoc with the National Institutes of Health in Maryland, USA from 2009 to 2013. Since 2014 he is our Senior Scientist at CyTuVax.

Currently, Dr. Almeida is leading the clinical development and coordination of the Phase-2 clinical trial of HBAI20 - Adjuvant-enhanced hepatitis B vaccine for non-responders.

 

 

Latest news

showCyTuVax is currently testing its vaccine technology in a clinical Phase 2 study of a vaccine for hepatitis B non-responders

Where we are

About us

CyTuVax B.V.
Oxfordlaan 55
6229 EV Maastricht
The Netherlands

+31-433881424
This email address is being protected from spambots. You need JavaScript enabled to view it.